|
|
nucleosome disassembly
|
GO:0006337 |
1 |
0.882
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.867
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.772
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.770
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.693
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.671
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.666
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.660
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.608
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.593
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.582
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.563
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.555
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.552
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.551
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.547
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.537
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.523
|
|
|
|
regulation of cd4 positive alpha beta t cell activation
|
GO:2000514 |
24 |
0.493
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.462
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.433
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.416
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.406
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.399
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.395
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.393
|
|
|
|
negative regulation of t helper 2 cell differentiation
|
GO:0045629 |
4 |
0.384
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.383
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.379
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.376
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.364
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.364
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.352
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.352
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.349
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.337
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.314
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.305
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.305
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.303
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.293
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.288
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.283
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.278
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.275
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.274
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.261
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.257
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.254
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.250
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.244
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.242
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.239
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.238
|
|
|
|
regulation of cd4 positive alpha beta t cell differentiation
|
GO:0043370 |
21 |
0.234
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.234
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.231
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.229
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.226
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.225
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.224
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.217
|
|
|
|
pharyngeal system development
|
GO:0060037 |
17 |
0.216
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.202
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.202
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.197
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.197
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.194
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.193
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.191
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.191
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.190
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.185
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.185
|
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.182
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.182
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.182
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.181
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.181
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.180
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.178
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.178
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.177
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.174
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.174
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.172
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.172
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.170
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.170
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.170
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.166
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.163
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.162
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.161
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.160
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.158
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.157
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.155
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.155
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.154
|
|
|
|
t cell differentiation involved in immune response
|
GO:0002292 |
30 |
0.151
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.151
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.149
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.144
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.143
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.138
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.138
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.136
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.136
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.135
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.134
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.133
|
Rat |
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.132
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.131
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.130
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.129
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.129
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.127
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.126
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.126
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.125
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.124
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.124
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.122
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.122
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.122
|
Mouse |
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.121
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.118
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.117
|
|
|
|
regulation of t helper cell differentiation
|
GO:0045622 |
14 |
0.117
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.116
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.116
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.115
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.114
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.113
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.112
|
Rat |
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.112
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.111
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.109
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.106
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.106
|
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.105
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.105
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.104
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.103
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.102
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.101
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.100
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.099
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.099
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.099
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.098
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.097
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.097
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.096
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.096
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.096
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.096
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.096
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.095
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.094
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.093
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.090
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.090
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.090
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.089
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.089
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.088
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.088
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.088
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.088
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.086
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.086
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.086
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.086
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.084
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.084
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.083
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.083
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.081
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.080
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.080
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.079
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.078
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.077
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.075
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.075
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.075
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.075
|
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
39 |
0.074
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.074
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.074
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.074
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.074
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.074
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.073
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.073
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.073
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.073
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.072
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.072
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.071
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.071
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.071
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.070
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.070
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.070
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.070
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.070
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.069
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.069
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.069
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.069
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.069
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.068
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.068
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.068
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.068
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.067
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.067
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.067
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.067
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.066
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.066
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.065
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.065
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.065
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.064
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.064
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.064
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.064
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.064
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.062
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.062
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.062
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.062
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.062
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.062
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.062
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.061
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.061
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.060
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.060
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.060
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.059
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.059
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.059
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.059
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.058
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.058
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.057
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.057
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.057
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.057
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.056
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.056
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.055
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.055
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.055
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.055
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.055
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.054
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.054
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.054
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.054
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.053
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.053
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.053
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.053
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.053
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.053
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.053
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.053
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.053
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.053
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.053
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.053
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.053
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.052
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.052
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.052
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.052
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.052
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.052
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.052
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.052
|
|
|
|
positive regulation of t helper 1 cell differentiation
|
GO:0045627 |
4 |
0.051
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.051
|
|
|
|
chromatin disassembly
|
GO:0031498 |
1 |
0.051
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.051
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.051
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.050
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.050
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.050
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.050
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.050
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.049
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.049
|
|
|
|
regulation of type 2 immune response
|
GO:0002828 |
18 |
0.049
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.049
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.048
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.048
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.048
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.047
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.047
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.047
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.047
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.047
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.046
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.046
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.046
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.046
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.045
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.045
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.045
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.044
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.044
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.044
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.044
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.044
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.044
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.044
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.044
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.044
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.044
|
|
|
|
t helper 2 cell differentiation
|
GO:0045064 |
12 |
0.044
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.043
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.043
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.043
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.043
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.043
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.042
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.042
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.041
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.041
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.041
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.041
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.041
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.041
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.041
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.041
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.041
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.041
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.040
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.040
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.040
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.040
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.040
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.040
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.039
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.039
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.039
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.039
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.039
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.039
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.039
|
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.039
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.039
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.039
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.039
|
|
|
|
positive regulation of cd4 positive alpha beta t cell differentiation
|
GO:0043372 |
14 |
0.038
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.038
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.038
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.038
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.038
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.038
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.038
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.038
|
|
|
|
striated muscle atrophy
|
GO:0014891 |
2 |
0.038
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.038
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.037
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.037
|
|
|
|
type 2 immune response
|
GO:0042092 |
23 |
0.037
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.037
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.037
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.037
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.037
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.037
|
|
|
|
metaphase anaphase transition of mitotic cell cycle
|
GO:0007091 |
9 |
0.037
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.037
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.037
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.036
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.036
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.036
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.036
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.036
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.036
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.035
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.035
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.035
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.035
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.035
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.035
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.035
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.035
|
Mouse |
|
|
gliogenesis
|
GO:0042063 |
141 |
0.035
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.035
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.035
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.035
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.034
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.034
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.034
|
|
|
|
regulation of cell fate commitment
|
GO:0010453 |
19 |
0.034
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.034
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.034
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.034
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.034
|
Mouse |
|
|
positive regulation of production of molecular mediator of immune response
|
GO:0002702 |
45 |
0.033
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.033
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.033
|
|
|
|
maintenance of protein location in nucleus
|
GO:0051457 |
2 |
0.033
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.033
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.033
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.033
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.033
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.033
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.033
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.033
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.033
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.033
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.033
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.032
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.032
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.032
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.032
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.032
|
Rat |
|
|
negative regulation of t cell differentiation
|
GO:0045581 |
23 |
0.031
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.031
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.031
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.031
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.031
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.031
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.031
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.031
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.031
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.031
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.031
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.031
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.031
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.031
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.031
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.031
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.030
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.030
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.030
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.030
|
Rat |
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.030
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.030
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.030
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.030
|
|
|
|
protein stabilization
|
GO:0050821 |
25 |
0.030
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.030
|
|
|
|
dna dependent dna replication maintenance of fidelity
|
GO:0045005 |
3 |
0.029
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.029
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.029
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
16 |
0.029
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.029
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.029
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.029
|
|
|
|
positive regulation of cd4 positive alpha beta t cell activation
|
GO:2000516 |
16 |
0.029
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.028
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.028
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.028
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.028
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.028
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.028
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.028
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.028
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
1 |
0.028
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.028
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.027
|
|
|
|
mrna transcription
|
GO:0009299 |
4 |
0.027
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.027
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.027
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.027
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.027
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.027
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.027
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.027
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.027
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.027
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.027
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.027
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.027
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.026
|
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.026
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.026
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.026
|
|
